QUADRANT CAPITAL GROUP LLC
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1650717
CINCINNATI, OH
Position in BMRN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,173,410
+$24,272 QoQ
Shares Held
20,772
+7.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026QUADRANT CAPITAL GROUP LLC holds $22,161,348 across 129 Biotechnology names. BMRN ranks #7 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,677 | $2,840,997 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,716 | $2,552,422 | |
| 3 | ARGX |
Argenx SE
|
2,778 | $2,028,634 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,363,639 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,144 | $1,361,288 | |
| 6 | EXEL |
Exelixis, Inc.
|
28,474 | $1,221,249 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
20,772 | $1,173,410 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
5,659 | $1,129,819 |
All Filings in BMRN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,173,410 | 20,772 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,149,138 | 19,336 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $239,278 | 4,418 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $668,325 | 12,158 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $778,296 | 11,010 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $116,736 | 1,776 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $78,584 | 1,118 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $35,484 | 431 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $14,411 | 165 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,559 | 151 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $11,679 | 132 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $39,786 | 459 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $50,662 | 521 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $23,906 | 231 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $21,022 | 248 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $29,418 | 355 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $9,483 | 123 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $21,469 | 243 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $18,163 | 235 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $20,442 | 245 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $26,352 | 349 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $20,519 | 234 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $18,791 | 247 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $94,725 | 768 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $137,055 | 1,622 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||